These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1375956

  • 1. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine. II. Characterization of induced effector cells and the mechanism of induction.
    Sharma BS, Mhaskar S, Balazs L, Jin A, Smee DF.
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):21-38. PubMed ID: 1375956
    [Abstract] [Full Text] [Related]

  • 2. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice.
    Sharma BS, Mhaskar S, Balazs L, Siaw M.
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650
    [Abstract] [Full Text] [Related]

  • 3. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL, Chourmouzis E, MacIntyre JP, Lee S, Goodman MG.
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [Abstract] [Full Text] [Related]

  • 4. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC, Bonavida B.
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [Abstract] [Full Text] [Related]

  • 5. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC, Bonavida B.
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [Abstract] [Full Text] [Related]

  • 6. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL, Chourmouzis E, Sigindere J, MacIntyre JP, Capetola RJ, Lau CY.
    Cell Immunol; 1993 Apr 01; 147(2):302-12. PubMed ID: 8453674
    [Abstract] [Full Text] [Related]

  • 7. Activation of murine natural killer cells and macrophages by 8-bromoguanosine.
    Koo GC, Jewell ME, Manyak CL, Sigal NH, Wicker LS.
    J Immunol; 1988 May 01; 140(9):3249-52. PubMed ID: 2452203
    [Abstract] [Full Text] [Related]

  • 8. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA, Pedersen KF, Welsh RM.
    J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814
    [Abstract] [Full Text] [Related]

  • 9. Successful immunotherapy of murine melanoma metastases with 7-thia-8-oxoguanosine.
    Sharma BS, Balazs L, Jin A, Jolley WB, Robins RK.
    Clin Exp Metastasis; 1991 Jul 15; 9(5):429-39. PubMed ID: 1914279
    [Abstract] [Full Text] [Related]

  • 10. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM.
    J Immunol; 1986 Jun 15; 136(12):4674-80. PubMed ID: 3486908
    [Abstract] [Full Text] [Related]

  • 11. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ, Taramelli D, Holden HT, Varesio L.
    J Immunol; 1983 Apr 15; 130(4):1974-9. PubMed ID: 6187831
    [Abstract] [Full Text] [Related]

  • 12. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C, Lopez C.
    J Immunol; 1986 May 01; 136(9):3473-80. PubMed ID: 2420891
    [Abstract] [Full Text] [Related]

  • 13. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV, Welsh RM, Haspel MV.
    J Immunol; 1986 Feb 15; 136(4):1446-53. PubMed ID: 3003198
    [Abstract] [Full Text] [Related]

  • 14. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
    Ting CC, Hargrove ME, Yun YS.
    J Immunol; 1988 Aug 01; 141(3):741-8. PubMed ID: 3260909
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic and morphologic profile of endogenous and pyrimidinone-activated murine NK cells.
    Lotzová E, Savary CA, Lowlachi M, Murasko DM.
    J Immunol; 1986 Jan 01; 136(2):732-40. PubMed ID: 2416824
    [Abstract] [Full Text] [Related]

  • 16. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
    Ellis TM, McKenzie RS, Simms PE, Helfrich BA, Fisher RI.
    J Immunol; 1989 Dec 15; 143(12):4282-6. PubMed ID: 2512355
    [Abstract] [Full Text] [Related]

  • 17. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A, Nowicky JW.
    Drugs Exp Clin Res; 1996 Dec 15; 22(3-5):103-13. PubMed ID: 8899312
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S, Naruo K, Shiho O, Tsukamoto K.
    Immunology; 1986 Oct 15; 59(2):251-9. PubMed ID: 3490435
    [Abstract] [Full Text] [Related]

  • 19. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF, Welsh RM.
    J Immunol; 1985 Nov 15; 135(5):3537-41. PubMed ID: 2413125
    [Abstract] [Full Text] [Related]

  • 20. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
    Stanková J, Rola-Pleszczynski M.
    J Immunol; 1985 Dec 15; 135(6):3719-28. PubMed ID: 2415584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.